Zhangzhou Pientzehuang Pharmaceutical., Ltd

Shanghai Stock Exchange 600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2023: USD 310.80 M

Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow is USD 310.80 M for the year ending December 31, 2023, a -68.79% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2022 was USD 995.97 M, a 1,268.99% change year over year.
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2021 was USD 72.75 M, a -67.63% change year over year.
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2020 was USD 224.76 M, a 277.99% change year over year.
Zhangzhou Pientzehuang Pharmaceutical., Ltd Operating Cash Flow for the year ending December 31, 2019 was USD -126.28 M, a -241.84% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Shanghai Stock Exchange: 600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

CEO	Mr. Jin Ming Huang
IPO Date	June 16, 2003
Location	China
Headquarters	Pien Tze Huang Building
Employees	2,789
Sector	Health Care
Industries Pharmaceuticals Cosmetics Drugstores & Retail Pharmacies

Description

Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. The company's products include medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health foods. The company is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd is a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.

Key trends

Past 5 years